Back to Acceleration Radar
WDFCWD-40 Company
Industrials · Major Chemicals · Mid
$212.71+1.20%
As of 23 Oct 2026Mkt cap $2.8B
Stage 13
WAIT
Fundamentals
49.3/75
Technical
12.0/15
Independent
61.3/90
GCAE viewelevated earnings event risk blocks an independent BUY decision
Price
- 1M
- +7.9%
- 3M
- −8.9%
- 6M
- −5.4%
- 1Y
- +5.8%
Financials & valuation
Cached filing evidence · as of 2026-10-02
Valuation
- P/E
- 32.3xHist median 36.7x
- Forward P/E
- —No validated forward-estimate source
- Price / FCF
- 36.3x
- FCF yield
- 2.8%
Quality
- ROIC
- 31.3%
- Operating margin
- 16.7%
- FCF margin
- 13.5%
- Current ratio
- 2.8x
Growth
- Revenue growth
- +5.0%Latest FY YoY
- Revenue CAGR
- +6.2%
- EPS CAGR
- +7.1%
- FCF CAGR
- +4.6%
Capital
- Share-count trend
- −0.1%3Y annualised
- Net debt
- $40M0.5x OCF
Annual trend
- CAGR 2021–2025
- +6.2%
- Latest · 2025
- $1B
- YoY
- +5.0%
GCAE Research
- Quality Research
- NOT FLAGGED
- Acceleration Radar
- EARLY IGNITION
- THE ONE
- NOT FLAGGED
- Final / Opportunity
- UNRESEARCHED · NEW RESEARCH
Key takeaway
Awaiting four-lens research.
Unresolved question
No reliable unresolved question is available from the current committed evidence.
Watch next
- Next earnings · 2027-01-07
- New current Route A/Route B candidate has no completed four-lens research.
More details & evidence
Production decision
- Stage 13
- WAIT
- Technical state
- early-recovery
- Rotation
- headwind
- Evidence
- fresh
Presentation freshness
- Stage 11 market
- 2026-10-23 · Massive
- Financial cache
- 2026-10-02
- Quality Research
- NOT FLAGGED
- THE ONE
- NOT FLAGGED
Authority
- Company page
- Presentation only
- Scores
- Frozen GCAE production outputs
- Research
- Research-only lanes; no score override
- Private portfolio
- Not loaded